Here we go again. From the New York Health Department: Anyone Who Ate Food From ilili Restaurant During January 31 – February ...

with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given 6 or 12 to 18 months after the first dose in accordance with the ...

2 National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science & School of Public Health, Xiamen University, Xiamen, China Objective This study aimed to ...

The Kaiser Permanente Hawaii Viral Hepatitis Clinic reached a milestone by curing its 1,000th patient of hepatitis C. “It’s a very satisfying thing to make that call and tell someone they’re cured,” ...

Hawaii’s Kaiser Permanente Viral Hepatitis Clinic has reached a major milestone toward combative Hepatitis outcomes. On ...

The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver ...

Viral hepatitis is as much a public health problem in the UT as is tuberculosis. Hepatitis means “inflammation of the liver” that can over a period of time, may or may not cause irreversible injury to ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths increased from 1.1 million in 2019 to 1.3 million in 2022, rates now similar ...

An estimated 2 million adults in the US have chronic hepatitis C, with new infections on the rise. Many patients are unaware ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...